Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study

• Published in: BMC public health Vol. 19; no. 1; p. 1112
• Main Authors: Kim, Hyungtae, Kim, Siin, Han, Sola, Rane, Pratik P, Fox, Kathleen M, Qian, Yi, Suh, Hae Sun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.08.2019; BioMed Central; BMC
• Subjects: Angina pectoris; Atherosclerosis; Atherosclerotic cardiovascular disease; Cardiovascular diseases; Coronary artery bypass; Death; Diabetes mellitus; Heart attack; Hypertension; Incidence; Ischemia; Medical research; Prevalence; Risk factors; Statistics; Stroke; Transient ischemic attack; South Korea; Atherosclerotic cardiovascular disease; Prevalence; Incidence
• ISSN: 1471-2458; 1471-2458
• DOI: 10.1186/s12889-019-7439-0

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading causes of mortality. However, it is more difficult to identify prevalence and incidence of a disease than the mortality owing to the lack of national-level statistics. Few studies have examined the prevalence and incidence of ASCVD and its risk factors since 2012. This study aimed to estimate the prevalence and incidence of ASCVD and its risk factors in Korea using national claims data. We conducted a retrospective analysis using the national claims data of the Health Insurance Review and Assessment Service. Patients aged ≥18 years with ASCVD (defined as myocardial infarction, angina, coronary revascularization, peripheral artery disease, ischemic stroke, and transient ischemic attack) were identified between January 1, 2014 and December 31, 2015. Patients at high risk for ASCVD (defined as hypertension, diabetes mellitus, and dyslipidemia without ASCVD during the baseline period) were identified between January 1, 2015 and December 31, 2015. We estimated the prevalence, cumulative incidence, and incidence density. These were further stratified by age and sex. The respective denominators for prevalence and incidence were the census population and the at-risk population (defined as the population without respective disease 1 year prior to the respective disease identification). Among the included Korean adult patients, the overall prevalence of clinical ASCVD per 1000 individuals was 98.25 in 2014 and 101.11 in 2015. The respective cumulative incidence and incidence density rates of ASCVD per 1000 individuals were 65.30 and 68.03 in 2014, and 67.05 and 69.94 in 2015, respectively. Peripheral artery disease seemed to drive the increase in the total prevalence and incidence of ASCVD. The prevalence and incidence of ASCVD continued to increase with age until 79 years. This national population-based study confirmed the high prevalence and incidence of ASCVD and its risk factors in the adult population of South Korea. We suggest that more intensive treatment and prevention are needed to prevent ASCVD.